GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Common Stock

Avicanna (TSX:AVCN) Common Stock : C$81.03 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Avicanna Common Stock?

Avicanna's quarterly common stock increased from Jun. 2023 (C$80.05 Mil) to Sep. 2023 (C$80.18 Mil) and increased from Sep. 2023 (C$80.18 Mil) to Dec. 2023 (C$81.03 Mil).

Avicanna's annual common stock increased from Dec. 2021 (C$66.24 Mil) to Dec. 2022 (C$74.89 Mil) and increased from Dec. 2022 (C$74.89 Mil) to Dec. 2023 (C$81.03 Mil).

Avicanna Common Stock Historical Data

The historical data trend for Avicanna's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Common Stock Chart

Avicanna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 46.03 57.47 66.24 74.89 81.03

Avicanna Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.89 78.32 80.05 80.18 81.03

Avicanna Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Avicanna (TSX:AVCN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Common Stock
Comparable Companies
TSXV:PCLO XCNQ:TIUM.U TSXV:CANB TSXV:LSL XCNQ:GDNS TSX:LABS XCNQ:ACRG.A.U TSX:AVNT XCNQ:BNXT XCNQ:CXXI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AVCNF:USA 0NN:Germany
Address
480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Website
https://www.avicanna.com
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.
Executives
Sheldon Inwentash 10% Security Holder

Avicanna (TSX:AVCN) Headlines

No Headlines